EXECUTIVE ENGAGEMENTS
OUTREACH
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPETITORS
* Login for a full stack data experience
DATE
APR 2021
TABLES
165
PAGES
236
EDITION
8
PRICE
USD $4950
HIGHLIGHTS
SELECT PLAYERS
Becton, Dickinson and Company; Eppendorf AG; F. Hoffmann-La Roche AG; GE Healthcare; Lonza Group AG; Merck KgaA; Nova Biomedical Corporation; Sartorius Stedim Biotech SA; Thermo Fisher Scientific, Inc.
SEGMENTS
» Application (Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications) » End-Use (Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry, Other End-Uses) » Product (Upstream Products, Downstream Products)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Impact of Covid-19 and a Looming Global Recession |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
4. GLOBAL MARKET PERSPECTIVE |
World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Upstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Upstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Downstream Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Downstream Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Recombinant Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Recombinant Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Monoclonal Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Monoclonal Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Antibiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Antibiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Contract Manufacturing Organizations (CMOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Contract Manufacturing Organizations (CMOs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Academic and Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Food Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Food Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
USA Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
CANADA |
Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Canada Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
JAPAN |
Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Japan Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
CHINA |
China Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
China Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
EUROPE |
Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Biopharmaceutical Fermentation Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
FRANCE |
France Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
France Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
GERMANY |
Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Germany Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
ITALY |
Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Italy Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
UNITED KINGDOM |
UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
UK Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF EUROPE |
Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Rest of Europe Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Asia-Pacific Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
REST OF WORLD |
Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Product - Upstream Products and Downstream Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Product - Percentage Breakdown of Value Sales for Upstream Products and Downstream Products for the Years 2012, 2020 & 2027 |
Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Biopharmaceutical Fermentation Systems by Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by Application - Percentage Breakdown of Value Sales for Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics and Other Applications for the Years 2012, 2020 & 2027 |
Rest of World Current & Future Analysis for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Biopharmaceutical Fermentation Systems by End-Use - Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Biopharmaceutical Fermentation Systems by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs), Academic and Research Institutes, Food Industry and Other End-Uses for the Years 2012, 2020 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 41 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com